Despite the lack of clinical significance for FOXP3+ Tregs alone, their combination with CD8+ TILs (CD8+/FOXP3- vs other) further enhanced the prognostic value of CD8 in our series, which supports the notion that Tregs can contribute to tumor progression [15]. Here, CD8A is linked to neoplasm.